Enrique de Álava (Enrique de Alava, Enrique de Álava Casado)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 33

Top Venues

Cell death & disease

International journal of molecular sciences

Cancers

JCO precision oncology

University of Seville

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Seville Oct 20 2016

Spain

Professor :: Pathology

Hospital Universitario Virgen del Rocío May 01 2013

Spain

Chairman :: Pathology

Consejo Superior de Investigaciones Científicas May 28 2003 - Apr 30 2013

Spain

Full Research Professor :: Pathology

Education History

Universidad de Navarra Jan 01 1990 - Dec 15 1993

Spain

PHD :: Pathology

Publications

Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Carmen Salguero-Aranda, Elena Di Blasi, Lourdes Galán, Laura Zaldumbide Dueñas, Gema Civantos, David Marcilla, Enrique de Álava, Juan Díaz Martín
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International journal of molecular sciences 25 (3) (2024)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
Nadia Mensali, Hakan Köksal, Sandy Joaquina, Patrik Wernhoff, Nicholas P Casey, Paola Romecin, Carla Panisello, Rene Rodriguez, Lene Vimeux, Asta Juzeniene, Marit R Myhre, Anne Fåne, Carolina Castilla Ramírez, Solrun Melkorka Maggadottir, Adil Doganay Duru, Anna-Maria Georgoudaki, Iwona Grad, Andrés Daniel Maturana, Gustav Gaudernack, Gunnar Kvalheim, Angel Montero Carcaboso, Enrique de Álava, Emmanuel Donnadieu, Øyvind S Bruland, Pablo Menendez, Else Marit Inderberg, Sébastien Wälchli
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma. Nature communications 14 (1) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés, Ana Belén Herrera-Campos, Joaquin Olmedo-Pelayo, Carmen Jordán Perez, José Expósito, Enrique de Álava, Ana Teresa Amaral, Francisco O' Valle, Angel Garcia Diaz, Francisco Javier Oliver
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. Cell death & disease 14 (2) (2023)
Daniel Delgado-Bellido, Francisco Javier Oliver, María Victoria Vargas Padilla, Laura Lobo-Selma, Antonio Chacón-Barrado, Juan Díaz Martín, Enrique de Álava
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation. International journal of molecular sciences 24 (11) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
Daniel José García-Domínguez, Nabil Hajji, Roser López-Alemany, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Francisco J Morón Civanto, Santiago Rello-Varona, Eduardo Andrés León, Adrián Benito, Hector C Keun, Jaume Mora, Òscar Martínez Tirado, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene 41 (18) (2022)
Pilar Puerto-Camacho, Juan Díaz Martín, Joaquín Olmedo-Pelayo, Alfonso Bolado-Carrancio, Carmen Salguero-Aranda, Carmen Jordán-Pérez, Marina Esteban-Medina, Inmaculada Álamo-Álvarez, Daniel Delgado-Bellido, Laura Lobo-Selma, Joaquín Dopazo, Ana Sastre, Javier Alonso, Thomas G P Grünewald, Carmelo Bernabéu, Adam Byron, Valerie G Brunton, Ana Teresa Amaral, Enrique de Álava
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions. International journal of molecular sciences 23 (15) (2022)
Carmen Salguero-Aranda, Joaquín Olmedo-Pelayo, Enrique de Álava, Ana Teresa Amaral, Juan Díaz Martín
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. Cancers 14 (24) (2022)
Enrique de Álava, María Jesús Pareja, David Carcedo, Natalia Arrabal, José-Francisco García, Reyes Bernabé
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective. Expert review of pharmacoeconomics & outcomes research 22 (6) (2022)
David S Shulman, Sarah B Whittle, Didier Surdez, Kelly M Bailey, Enrique de Álava, Jason T Yustein, Adam Shlien, Masanori Hayashi, Alexander J R Bishop, Brian D Crompton, Steven G DuBois, Neerav Shukla, Patrick J Leavey, Stephen L Lessnick, Heinrich Kovar, Olivier Delattre, Thomas G P Grünewald, Cristina R Antonescu, Ryan D Roberts, Jeffrey A Toretsky, Franck Tirode, Richard G Gorlick, Katherine A Janeway, Damon R Reed, Elizabeth R Lawlor, Patrick J Grohar
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. NPJ precision oncology 6 (1) (2022)
Florencia Cidre-Aranaz, Sarah Watson, James F Amatruda, Takuro Nakamura, Olivier Delattre, Enrique de Álava, Uta Dirksen, Thomas G P Grünewald
Small round cell sarcomas. Nature reviews. Disease primers 8 (1) (2022)
Carmen Salguero-Aranda, Joaquín Olmedo-Pelayo, Enrique de Álava, Ana Teresa Amaral, Juan Díaz Martín
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. Cancers 14 (24) (2022)
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet, Luis de la Cruz Merino, Jaume Catala-Mora, Enrique de Álava, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers 14 (21) (2022)
Daniel José García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Rocío M de Pablos, Ana M Espinosa-Oliva, Eduardo Andrés León, Laura Carmen Terrón-Camero, Rocío Flores-Campos, Guillem Pascual-Pasto, María José Robles, Isidro Machado, Antonio Llombart-Bosch, Giovanna Magagnoli, Katia Scotlandi, Angel Montero Carcaboso, Jaume Catala-Mora, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma. Oncogene 40 (39) (2021)
Carmen Salguero-Aranda, Paula Martínez-Reguera, David Marcilla, Enrique de Álava, Juan Díaz Martín
Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors. Cancers 13 (20) (2021)
Stefan K Zöllner, James F Amatruda, Sebastian Bauer, Stéphane Collaud, Enrique de Álava, Steven G DuBois, Jendrik Hardes, Wolfgang Hartmann, Heinrich Kovar, Markus Metzler, David S Shulman, Arne Streitbürger, Beate Timmermann, Jeffrey A Toretsky, Yasmin Uhlenbruch, Volker Vieth, Thomas G P Grünewald, Uta Dirksen
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. Journal of clinical medicine 10 (8) (2021)
Pablo Rodríguez-Núñez, Laura Romero-Pérez, Ana T Amaral, Pilar Puerto-Camacho, Carmen Jordán, David Marcilla, Thomas G P Grünewald, Javier Alonso, Enrique de Álava, Juan Díaz Martín
Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma. The Journal of pathology 250 (4) (2020)
Laura Pignata, Orazio Palumbo, Flavia Cerrato, Basilia Acurzio, Enrique de Álava, Josep Roma, Soledad Gallego, Jaume Mora, Massimo Carella, Andrea Riccio, Gaetano Verde
Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors. Cancers 12 (11) (2020)
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Enrique Blanco, María Sánchez-Jiménez, Pablo Táboas, Soledad Gómez-González, Cecilia Ballaré, Daniel José García-Domínguez, Estela Prada, Lourdes Hontecillas-Prieto, Angel Montero Carcaboso, Òscar Martínez Tirado, Inmaculada Hernández-Muñoz, Enrique de Álava, Cinzia Lavarino, Luciano Di Croce, Jaume Mora
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Science advances 6 (43) (2020)
Juan Díaz-Martín, Michele Biscuola, Jonatan Benoit, David Marcilla, Gema Civantos, Enrique de Álava
What's in a name? Molecular subclassification of sarcomas creates fresh challenges. The Journal of pathology 247 (4) (2019)

Enrique de Álava.css-eqlu8i{font-size:small;padding-left:4px;} (Enrique de Alava, Enrique de Álava Casado)

Publication Activity (10 Years)

Top Topics

Top Venues

Enrique de Álava (Enrique de Alava, Enrique de Álava Casado)